Alcon, Inc. ALC delivered third-quarter 2025 core earnings per share (EPS) of 79 cents, down 2.5% from the year-ago quarter’s ...

Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum ...

The global eyecare company, with manufacturing and research facilities in Berks County, reduced its full-year projections in ...

Q3 2025 Management View CEO David Endicott pointed to building momentum in the second half of 2025, with particular strength in equipment and ocular health. Endicott highlighted, "the launch [of Unity ...

Aug 20 (Reuters) - Shares in Alcon (ALCC.S), opens new tab fell as much as 11.6% on Wednesday after the Swiss-American eye care group cut its 2025 sales outlook late on Tuesday flagging the impact of ...

Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook late on Tuesday, citing increased tariff impact. The company forecasts a full-year ...

Alcon Inc (ALC) reports a 5% increase in revenue, driven by robust performance in surgical and ocular health segments, despite facing margin challenges and tariff-related costs.

Alcon Inc ALC posted better-than-expected earnings for the second quarter and cut its 2025 outlook late on Tuesday, citing increased tariff impact. The company reported adjusted earnings of 76 cents ...

Fort Worth officials are lining up $6M in economic incentives to entice one of the city’s biggest employers to relocate a pair of manufacturing lines from Europe to Cowtown. Fort Worth Economic ...

Tryptyr is used to treat dry eye disease. Alcon also has launched an ECP campaign focusing on the speed of rapid natural tear production with Tryptyr. The campaign features ECP tools, including videos ...